Hepatocyte proliferation rate is a powerful parameter for predicting hepatocellular carcinoma development in liver cirrhosis

Journal of Clinical Pathology - Molecular Pathology

Volumn 51, Issue 2, 1998, Pages 96-101

  Borzio, M ^a   Trere D ^b   Borzio, F ^a   Ferrari, A R ^a   Bruno, S ^c   Roncalli, M ^c   Colloredo, G ^d   Leandro, G ^e   Oliveri, F ^f   Derenzini, M ^b,g  

^a FATEBENEFRATELLI HOSPITAL   (Italy)

^b UNIVERSITY OF BOLOGNA   (Italy)

^c UNIVERSITY OF MILAN   (Italy)

^d BOLOGNINI HOSPITAL   (Italy)

^e Castellana Grotte Hospital   (Italy)

^f MOLINETTE HOSPITAL   (Italy)

^g UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

AgNOR proteins; Hepatocellular carcinoma; Hepatocyte proliferation; Image analysis; Liver cirrhosis; Multivariate analysis

Indexed keywords

HEPATITIS B SURFACE ANTIGEN;

ADULT; AGED; ARTICLE; CANCER RISK; CELL PROLIFERATION; CHROMOSOME NOR; CONTROLLED STUDY; FEMALE; HEPATITIS C; HUMAN; HUMAN TISSUE; IMAGE ANALYSIS; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; MAJOR CLINICAL STUDY; MALE; MITOSIS RATE; MULTIVARIATE ANALYSIS; PREDICTION; PRIORITY JOURNAL; RISK FACTOR;

EID: 0005048256     PISSN: 13668714     EISSN: None     Source Type: Journal    
DOI: 10.1136/mp.51.2.96     Document Type: Article

References (29)

1. Colombo M, De Franchis R, Del Ninno E, et al. Hepatocellular carcinoma in Italian patients with cirrhosis. N Engl J Med 1901;325:675-80.
2. Borzio M, Savino B, Roncalli M, et al. Liver cell dysplasia is a major risk factor for hepatocellular carcinoma in cirrhosis: a prospective study. Gastroenterology 1995;108: 812-17.
3. Ganne-Carrie N, Chastang C, Chapel F, et al. Predictivescore for the development of hepatocellular carcinoma and additional value of liver large cell dysplasia in western patients with cirrhosis. Hepatology 1906;23:1112-18.
4. Derenzini M, Trerè D, Oliven F, et al. Is high AgNOR quantity in hepatocytes associated with increased risk of hepatocellular carcinoma in chronic liver disease? J Clin Pathol 1993;46:727-9.
5. Derenzini M, Ploton D. Interphase nucleolar organizer regions in cancer cells. Int Rev Exp Pathol 1991;32:149-92.
6. Pession A, Farabegoli F, Trerè D, et al. The Ag-NOR proteins and transcription and duplication of ribosomal genes in mammalian cell nuclei. Chromosoma 1991;100: 242-50.
7. Sirri V, Roussel P, Trerè D, et al. Amount variability of total AgNOR proteins, nucleolin and protein B23 in cells stimulated to proliferate. J Histochem Cytochem 1995;43:887-93.
8. Bolondi L, Gramantieri L, Chieco P, et al. Enzymatic cytochemistry, ploidy and AgNOR quantitation in small undefined nodular lesions in liver cirrhosis. Dig Dis Sci 1996;41: 4:800-8.
9. Kuo G, Choo QL, Alter J, et al. An assay for circulating antibodies to a major etiologic virus of human non-A non-B hepatitis. Science 1989;244:362-4.
10. Ploton D, Menager M, Jeannesson P, et al. Improvement in the staining and in the visualization of the argyrophilic proteins of the nucleolar organizer regions at the optical level. Histochem J 1986;18:5-14.
11. Öfner D, Bankflavi A, Riehemann K, et al. Wet autoclave pretreatment improves the visualization of silver-stained nucleolar organizer-region-associated proteins in routinely formalin-fixed and paraffin-embedded tissues. Mod Pathol 1994;7:946-50
12. Anthony PP, Ishak K, Nayak NC, et al. The morphology of cirrhosis. J Clin Pathol 1978;31:395-414.
13. Gibson JB, Sobin LH. Histological typing of tumors of the liver, biliary tract and pancreas. International histological classification of tumors number 20. Geneva: World Health Organisation, 1978:12-30.
14. Anthony PP, Vogel CL, Barker LF. Liver cell dysplasia: a premalignant condition. J Clin Pathol 1973;26:217-23.
15. Mourad WA, Erkman-Balis B, Livingston S, et al. Argyrophilic nucleolar organizer regions in breast carcinoma: correlation with DNA flow cytometry, histo-pathology and lymph node status. Cancer 1992;69:1739-44.
16. Mourad WA, Connelly JF, Sembera DL, et al. Correlation of two argyrophilic nucleolar organizer region counting methods with bromodeoxyuridine labeling index: a study of metastatic tumors of the brain. Hum Pathol 1993;24:206-10.
17. Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958;53:457-81.
18. Cox DR. Regression models and life-tables. J R Stat Soc B 1972;34:87-220.
19. Manakata S, Hendricks JB. Effect of fixation time and microwave oven heating time on retrieval of the Ki67 antigen from paraffin embedded tissue. J Histochem Cytochem 1993;41:1241-6.
20. Torp SH, Proliferative activity in human ganglioblastomas: evaluation of different Ki67 equivalent antibodies. J Clin Pathol Mol Pathol 1997;50:198-200.
21. Tarao K, Shimizu A, Ohkawa S, et al. Development of hepatocellular carcinoma associated with increases in DNA synthesis in the surrounding cirrhosis. Gastroenterology 1992;103:595-600.
22. Tarao K, Ohkawa S, Shimizu A, et al. The male preponderance of hepatocellular carcinoma associated cirrhotic patients may depend on the higher DNA synthetic activity of cirrhotic tissue in men. Cancer 1993;72:369-74.
23. Ballardini G, Groff P, Zoli M, et al. Increased risk of hepatocellular carcinoma development in patients with cirrhosis with high hepatocellular proliferation. J Hepatol 1994;20: 218-22.
24. Tarao K, Ohkawa S, Shimizu A, et al. Significance of hepatocellular proliferation in the development of hepatocellular carcinoma from anti-hepatitis C virus-positive cirrhotic patients. Cancer 1994;73:1149-54.
25. Farber E. Response of the liver to carcinogenesis. In: Farber E, Fisher M, eds. Injury of the liver. Part A. New York: Marcel Dekker, 1979:445-6.
26. Trerè D, Derenzini M, Sirri V, et al. Qualitative and quantitative analysis of AgNOR proteins in chemically-induced rat liver carcinogensis. Hepatology 1996;24:1269-73.
27. Huang SN, Chisari FV. Strong, sustained hepatocellular proliferation precedes hepatocarcinogenesis in hepatitis B surface antigen transgenic mice. Hepatology 1995;21:620-6.
28. Crocker J, McGovern J. Nucleolar organizer regions in normal, cirrhotic and carcinomatous livers. J Clin Pathol 1998: 41:1044-8.
29. Mazzella G, Accogli E, Sottili S, et al. Alpha interferon treatment may prevent hepatocellular carcinoma in HCV-related liver cirrhosis. J Hepatol 1996;24:141-7.